5-177273682-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_022455.5(NSD1):c.5520A>T(p.Glu1840Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E1840E) has been classified as Likely benign.
Frequency
Consequence
NM_022455.5 missense
Scores
Clinical Significance
Conservation
Publications
- Beckwith-Wiedemann syndrome due to NSD1 mutationInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Sotos syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Sotos syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_022455.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NSD1 | NM_022455.5 | MANE Select | c.5520A>T | p.Glu1840Asp | missense | Exon 17 of 23 | NP_071900.2 | ||
| NSD1 | NM_001409301.1 | c.5520A>T | p.Glu1840Asp | missense | Exon 17 of 23 | NP_001396230.1 | |||
| NSD1 | NM_001409302.1 | c.5520A>T | p.Glu1840Asp | missense | Exon 17 of 23 | NP_001396231.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NSD1 | ENST00000439151.7 | TSL:1 MANE Select | c.5520A>T | p.Glu1840Asp | missense | Exon 17 of 23 | ENSP00000395929.2 | ||
| NSD1 | ENST00000347982.9 | TSL:1 | c.4647A>T | p.Glu1549Asp | missense | Exon 18 of 24 | ENSP00000343209.5 | ||
| NSD1 | ENST00000687453.1 | c.5211A>T | p.Glu1737Asp | missense | Exon 14 of 20 | ENSP00000508426.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251448 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460388Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726596 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 1840 of the NSD1 protein (p.Glu1840Asp). This variant is present in population databases (rs140815139, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with NSD1-related conditions. Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt NSD1 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at